iShares Nasdaq Biotechnology Index Fund (IBB)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: SECURITY BROKERS, DEALERS & FLOTATION COMPANIES

400 HOWARD STREET SAN FRANCISCO, CA 94105

iShares Nasdaq Biotechnology Index Fund is an open-end management investment company. The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. As of Mar 31 2013, the Fund's total assets were $3,001,778,070 and the Fund's investment portfolio was valued at $3,001,263,855.

Data based on most recent fiscal year report
Market Cap9.384 Billion Shares Outstanding91.2 Million Avg Volume2.467 Million
View SEC Filings from IBB instead.
Q3 2018 All Institutions Hedge Funds 1
To trade IBB now:
Filers who had this stock in their top 10: 23 2 (0.19%)
13F Filers holding this stock: 614 36 (3.47%)
Aggregate 13F shares on 09/30/2018: 49.655 Million 2.28 Million
Aggregate 13F shares on 06/30/2018: 52.029 Million 2.079 Million
Percent change: -4.56% 9.65%
Funds creating new positions: 74 3
Funds Adding to an existing position: 188 13
Funds closing out their position: 44 8
Funds reducing their position: 205 11
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding IBB (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to

Exclude:

Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Acquired or Disposed Shares Owned Following Transaction Direct/Indirect Ownership
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments